🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Rosiglitazone (RSG) has been tested in clinical studies and is approved by ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-07-06
Trial ID
NCT00348309
Treatments Being Tested
The purpose of this study is to gain safety and efficacy information in pat...
Status
Completed
Location
Multiple Locations
Start Date
2002-05
Trial ID
NCT00044460
Treatments Being Tested
This study compares the effects of Avandamet (rosiglitazone maleate/metform...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-02
Trial ID
NCT00359112
Treatments Being Tested
Background: Latent autoimmune diabetes in adults \[LADA\] is a type 1 diabe...
Status
Unknown
Location
Diabetes Unit
Start Date
2007-04
Trial ID
NCT00776607
Treatments Being Tested
The purpose of this study is to demonstrate that the rosiglitazone/glimepir...
Status
Terminated
Location
GSK Investigational Site
Start Date
2010-04
Trial ID
NCT01453049
Treatments Being Tested
This study is a randomised double blind, parallel group, and will evaluate ...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2009-06
Trial ID
NCT00884533
Treatments Being Tested
Clinical features in patients with the familial early onset forms and the s...
Status
Terminated
Location
GSK Investigational Site
Start Date
2004-12
Trial ID
NCT00334568
Treatments Being Tested
RATIONALE: Rosiglitazone may help pituitary adenoma cells become more like ...
Status
Terminated
Location
Jonsson Comprehensive Cancer Center at UCLA
Start Date
2006-10
Trial ID
NCT00616642
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2009-07
Trial ID
NCT00933309
Treatments Being Tested
* To evaluate the effect of BAY73-4506 on the pharmacokinetics of probe sub...
Status
Completed
Location
Cross Cancer Institute
Start Date
2011-08-02
Trial ID
NCT01287598
Treatments Being Tested